Leaflet: information for the user
Gaviscon chewable tablets strawberry flavor
Sodium alginate, sodium hydrogen carbonate (sodium bicarbonate) and calcium carbonate
Read the entire leaflet carefully before starting to take this medicine, as it contains important information for you. Follow the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.
|
Contents of the leaflet:
It belongs to the group of medicines called other agents against peptic ulcer and gastroesophageal reflux.
It acts in two different ways:
Gaviscon is indicated for the symptomatic treatment of stomach hyperacidity and burning caused by acid reflux from the stomach, in adults and children over 12 years old.
You should consult a doctor if it worsens or does not improve after 7 days.
Do not take Gaviscon:
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medicine if: you have mild or moderate kidney problems, you have been diagnosed with sarcoidosis (inflammation that can affect multiple organs in the body), if you suffer from constipation or hemorrhoids, or you suffer from symptoms of stomach or intestinal diseases, appendicitis, or edema.
If you are taking or are going to take other medicines, you should separate their intake by 1 to 2 hours (see "Other medicines and Gaviscon").
Avoid prolonged use as it can cause kidney stones, as well as high doses over a long period, which can also cause high blood calcium levels or urine, kidney failure, or worsen it if you already have it.
The medicine should not be taken with milk or dairy products.
If the symptoms persist after 7 days of treatment, consult your doctor.
Children and adolescents
Gaviscon is not recommended for children under 12 years old.
Interference with laboratory tests
If you are going to have any laboratory tests (including blood tests, urine tests, skin tests that use allergens, etc.), inform your doctor that you are taking this medicine, as it may alter the results.
Other medicines and Gaviscon
Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medicine.
Before taking this medicine, inform your doctor if you are taking antibiotics (tetracyclines, quinolones), heart medicines such as cardiac glycosides (digoxin or digitoxin) or other medicines such as fluorides, phosphates, iron salts, ketoconazole, neuroleptics, thyroid hormones, penicillamine, glucocorticoids, chloroquine, bisphosphonates, or beta-blocker medicines (such as atenolol, metoprolol, propranolol) or estramustine, as it may affect the efficacy of these medicines.
Since Gaviscon can interfere with some medicines, after taking it, you should wait 2 hours before taking another oral medicine. If you have taken another medicine, before taking Gaviscon, you should wait 1 to 2 hours to get the maximum benefit from the treatment with that other medicine.
Taking Gaviscon with food and drinks
Like all antacids that contain calcium, this medicine should not be taken with large amounts of milk or dairy products, as it may cause increased blood calcium levels and milk-alkali syndrome (Burnett syndrome).
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
This medicine can be used during pregnancy and breastfeeding if taken according to these recommendations and not for a long time.
Since this medicine provides a significant amount of calcium in addition to what the pregnant or breastfeeding woman takes every day, pregnant or breastfeeding women should not exceed the amounts indicated in the section "3. How to take Gaviscon" and should not take large amounts of dairy products and milk at the same time (1 liter of milk contains 1.2 grams of elemental calcium).
Driving and using machines
This medicine does not affect the ability to drive or use machines.
Gaviscon contains sodium and aspartame.
This medicine contains 254.84 mg of sodium (main component of table salt/cooking salt) in each 4 tablets. This is equivalent to 12.74% of the maximum daily sodium intake recommended for an adult.
Consult your doctor or pharmacist if you need 7 or more tablets per day for a prolonged period, especially if you have been advised to follow a low-salt diet (sodium).
This medicine contains 35.2 mg of aspartame in each 4 tablets.
Aspartame contains a source of phenylalanine that may be harmful in case of phenylketonuria (PKU), a rare genetic disease in which phenylalanine accumulates because the body is unable to eliminate it properly.
Follow the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.
The recommended dose in adults, including elderly people and adolescents over 12 years old, is 2 to 4 tablets, as needed, 1 hour after meals and before bedtime. You can take a maximum of 16 tablets per day.
Kidney failure: caution is required in patients with low-salt diets (see section 2).
How to take
This medicine is taken orally.
Remove the tablets from the packaging and chew them.
If the symptoms persist after 7 days of continuous treatment, consult your doctor to rule out more serious diseases.
If you take more Gaviscon than you should
The symptoms of overdose include nausea and vomiting, constipation, fatigue, increased urine production, thirst, dehydration, and abnormal muscle weakness.
Drink plenty of water and consult your doctor or pharmacist.
In case of overdose or accidental ingestion, consult your doctor or pharmacist or go to a medical center or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Gaviscon
Do not take a double dose to make up for the missed doses.
When you need it, take it again as indicated in the section "3. How to take Gaviscon". If you have any other doubts about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone gets them.
During the use of the association of sodium alginate, sodium hydrogen carbonate (sodium bicarbonate), and calcium carbonate, the following side effects have been observed with the following frequencies:
Frequency not known (frequency cannot be estimated from the available data):
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Medicines and Health Products Agency (AEMPS) website (www.notificaram.es). By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store above 25°C.
Medicines should not be disposed of through wastewater or household waste. Deposit the packaging and medicines you no longer need in the pharmacy's SIGRE point. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Gaviscon composition
The active ingredients are 250 mg of sodium alginate, 133.5 mg of sodium hydrogen carbonate (sodium bicarbonate), and 80 mg of calcium carbonate.
The other ingredients (excipients) are macrogol, mannitol (E-421), aspartame (E-951), magnesium stearate, xylitol DC (which contains sodium carmellose), strawberry flavor (which contains corn starch, vegetable oil, propylene glycol (E-1520)), red iron oxide.
Appearance of the product and package contents
Gaviscon are pale pink, flat, chewable tablets with beveled edges and a strawberry flavor and odor.
They come in transparent, unprinted PVC/PE/PVdC strips with an aluminum foil layer in a cardboard box with a leaflet.
Each package may contain 4, 24, 32, 48, or 64 tablets.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Reckitt Benckiser Healthcare, S.A.
C/ Mataró, 28
08403 Granollers-Barcelona (Spain)
RB NL Brands B.V.
Schiphol Blvd 207, 1118 BH Schiphol, Netherlands
Date of the last revision of this leaflet:August 2020.
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/